slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
160,561-160,620 of 319,975
28
Azek | Investor Presentation Deck | 36 slidesAzek | Investor Presentation Deck | 36 slides · The AZEK Company
Pitch deck Investor relations 1 hit
29
Azek | Investor Presentation Deck | 36 slidesAzek | Investor Presentation Deck | 36 slides · The AZEK Company
Pitch deck Investor relations 1 hit
30
Includes definitions for Adjusted RONTA and rounding disclaimers.Azek | Investor Presentation Deck | 36 slides · The AZEK Company
Pitch deck Investor relations 1 hit
31
The slide uses a split-track timeline format to distinguish between organic growth and M&A activity.Azek | Investor Presentation Deck | 36 slides · The AZEK Company
Pitch deck Investor relations 1 hit
32
Uses two additive equations to visualize how growth and margin targets are achieved.Azek | Investor Presentation Deck | 36 slides · The AZEK Company
Pitch deck Investor relations 1 hit
33
Contains two distinct financial tables with detailed footnotes explaining non-GAAP adjustments.Azek | Investor Presentation Deck | 36 slides · The AZEK Company
Pitch deck Investor relations 1 hit
34
Contains three distinct financial reconciliation tables with detailed footnotes explaining adjustments.Azek | Investor Presentation Deck | 36 slides · The AZEK Company
Pitch deck Investor relations 1 hit
35
Includes detailed footnotes explaining specific adjustments.Azek | Investor Presentation Deck | 36 slides · The AZEK Company
Pitch deck Investor relations 1 hit
36
Azek | Investor Presentation Deck | 36 slidesAzek | Investor Presentation Deck | 36 slides · The AZEK Company
Pitch deck Investor relations 1 hit
01
Bausch Health Companies | Results Presentation Deck | 79 slidesBausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Attention1 hit
02
Includes a footnote regarding CAGR definition.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Attention1 hit
03
Bausch Health Companies | Results Presentation Deck | 79 slidesBausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Attention1 hit
04
Bausch Health Companies | Results Presentation Deck | 79 slidesBausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Attention1 hit
05
Bausch Health Companies | Results Presentation Deck | 79 slidesBausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · NeedLoop · Pattern Hunter1 hit
06
Bausch Health Companies | Results Presentation Deck | 79 slidesBausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · NeedLoop · Pattern Hunter1 hit
07
Includes a donut chart showing revenue breakdown by segment.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · NeedLoop · Pattern Hunter1 hit
08
Includes detailed footnotes regarding non-GAAP metrics and organizational restructuring.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · NeedLoop · Pattern Hunter1 hit
09
Includes GAAP and non-GAAP metrics with reported, constant currency, and organic change columns.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · NeedLoop · Pattern Hunter1 hit
10
Includes detailed footnotes explaining adjustments and specific financial events.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · NeedLoop · Pattern Hunter1 hit
11
Includes specific footnotes regarding debt settlement and restricted cash.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
12
The table uses a blue box to visually emphasize the 2021-2023 period with zero debt obligations.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
13
Bausch Health Companies | Results Presentation Deck | 79 slidesBausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
14
The slide includes detailed footnotes regarding non-GAAP adjustments and guidance methodology.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
15
The slide uses two separate waterfall-style bridges to explain changes in financial guidance.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
16
The slide uses a pie chart to show revenue distribution and bulleted lists to detail segment-specific performance metrics.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
17
The slide uses a mix of bar charts and line charts to illustrate recovery trajectories, with annotations highlighting specific performance periods.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
18
Includes a bar chart showing organic growth trends pre- and post-COVID-19.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
19
The slide uses trend lines to visually emphasize recovery trajectories for three pharmaceutical products.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
20
Includes a bar chart for organic growth, a donut chart for regional revenue, and callouts for top products by region overlaid on a world map.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
21
Includes non-GAAP metrics and specific product performance data.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
22
Bausch Health Companies | Results Presentation Deck | 79 slidesBausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
23
Includes clinical trial data for NOV03 vs Saline.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
24
Includes footnotes referencing clinical trial data and market statistics.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
25
The slide uses a grid-based timeline to map four different drug development programs against calendar years from 2019 to 2027.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
26
Bausch Health Companies | Results Presentation Deck | 79 slidesBausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
27
Bausch Health Companies | Results Presentation Deck | 79 slidesBausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
28
Uses a timeline-like flow diagram to show paths forward from 3Q21.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
29
The slide uses a dual-track timeline approach, separating 'Internal Organizational Design / Structure' from 'Capital Structure' events.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
30
Includes a footnote regarding the appointment status of the individuals.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · ActionLoop · Why Now1 hit
31
Bausch Health Companies | Results Presentation Deck | 79 slidesBausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
32
The slide uses a flow diagram to show how business lines were re-categorized under the new corporate structure.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
33
The slide uses a bridge-style table to show how reported figures were adjusted to restated figures.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
34
The slide uses specific CAGR ranges to communicate growth expectations.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
35
The slide uses a three-column layout to categorize updates by business unit.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
36
LOE = Loss of Exclusivity. Data shows significant revenue and profit declines for most units, with Salix being an exception.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
37
LOE = Loss of Exclusivity. Data shows significant revenue and profit declines across all business units due to patent expirations.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
38
LOE stands for Loss of Exclusivity. The table shows revenue and profit figures in millions of dollars.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
39
The table tracks inventory levels and period-over-period changes for specific business units.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
40
The slide highlights a 2% organic revenue decline for the segment. Includes detailed footnotes regarding non-GAAP metrics and segment reporting.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
41
Includes non-GAAP metrics like EBITA and organic growth.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
42
Includes non-GAAP metrics and segment-specific performance data.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
43
Includes a callout highlighting 35% organic revenue growth for Global Solta.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
44
The slide highlights a 6% decline in WELLBUTRIN/APLENZIN revenue as a key driver.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
45
The table compares Q1 2021 vs Q1 2020 performance with reported and constant currency variance metrics.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
46
The table tracks quarterly revenue in millions of dollars for the top 10 products ranked by 1Q21 performance.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
47
The table tracks revenue in millions of dollars for the top 10 products, ranked by 1Q21 performance.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
48
The table lists products by rank and provides quarterly revenue figures in millions of dollars.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
49
The table tracks revenue in millions of dollars for 10 products from 1Q20 to 1Q21.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
50
The table lists products by rank and provides revenue figures in millions of dollars for each of the last five quarters.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
51
The table lists products ranked by revenue in 1Q21, with historical data for the previous four quarters.Bausch Health Companies | Results Presentation Deck | 79 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit